Literature DB >> 36153473

Research Progress on the Role of Sirtuin 1 in Cerebral Ischemia.

Yijia Fangma1, Haitong Wan2, Chongyu Shao2, Liang Jin2, Yu He3.   

Abstract

A significant amount of evidence from the past few years has shown that Sirtuin 1 (SIRT1), a histone deacetylase dinucleotide of nicotinamide adenine dinucleotide (NAD+) is closely related to the cerebral ischemia. Several potential neuroprotective strategies like resveratrol, ischemia preconditioning, and caloric restriction exert their neuroprotection effects through SIRT1-related signaling pathway. However, the potential mechanisms and neuroprotection of SIRT1 in the process of cerebral ischemia injury development and recovery have not been systematically elaborated. This review summarized the the deacetylase activity and distribution of SIRT1 as well as analyzed the roles of SIRT1 in astrocytes, microglia, neurons, and brain microvascular endothelial cells (BMECs), and the molecular mechanisms of SIRT1 in cerebral ischemia, providing a theoretical basis for exploration of new therapeutic target in future.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Cerebral ischemia; Deacetylase; Molecular mechanisms; NAD+; SIRT1

Year:  2022        PMID: 36153473     DOI: 10.1007/s10571-022-01288-3

Source DB:  PubMed          Journal:  Cell Mol Neurobiol        ISSN: 0272-4340            Impact factor:   4.231


  90 in total

1.  Carbon Monoxide Potentiation of L-Type Ca2+ Channel Activity Increases HIF-1α-Independent VEGF Expression via an AMPKα/SIRT1-Mediated PGC-1α/ERRα Axis.

Authors:  Yoon Kyung Choi; Ji-Hee Kim; Dong-Keun Lee; Kwang-Soon Lee; Moo-Ho Won; Dooil Jeoung; Hansoo Lee; Kwon-Soo Ha; Young-Guen Kwon; Young-Myeong Kim
Journal:  Antioxid Redox Signal       Date:  2016-09-28       Impact factor: 8.401

Review 2.  Mitochondrial dysfunction - Silent killer in cerebral ischemia.

Authors:  Pramila Bakthavachalam; Prakash Srinivasan Timiri Shanmugam
Journal:  J Neurol Sci       Date:  2017-02-22       Impact factor: 3.181

Review 3.  NAD(+) Metabolism and the Control of Energy Homeostasis: A Balancing Act between Mitochondria and the Nucleus.

Authors:  Carles Cantó; Keir J Menzies; Johan Auwerx
Journal:  Cell Metab       Date:  2015-06-25       Impact factor: 27.287

Review 4.  The metabolic modulator PGC-1α in cancer.

Authors:  Frederic Bost; Lisa Kaminski
Journal:  Am J Cancer Res       Date:  2019-02-01       Impact factor: 6.166

5.  Melatonin alleviates asphyxial cardiac arrest-induced cerebellar Purkinje cell death by attenuation of oxidative stress.

Authors:  Jeong Hwi Cho; Hyun-Jin Tae; In-Shik Kim; Minah Song; Hyunjung Kim; Tae-Kyeong Lee; Young-Myeong Kim; Sungwoo Ryoo; Dae Won Kim; Choong-Hyun Lee; In Koo Hwang; Bing Chun Yan; Il Jun Kang; Moo-Ho Won; Jae-Chul Lee
Journal:  Exp Neurol       Date:  2019-06-26       Impact factor: 5.330

Review 6.  AMP-activated protein kinase: An attractive therapeutic target for ischemia-reperfusion injury.

Authors:  Rong Ding; Wei Wu; Zhou Sun; Zhi Li
Journal:  Eur J Pharmacol       Date:  2020-08-14       Impact factor: 4.432

7.  Mesenchymal Stem Cells (MSCs) Coculture Protects [Ca2+]i Orchestrated Oxidant Mediated Damage in Differentiated Neurons In Vitro.

Authors:  Adel Alhazzani; Prasanna Rajagopalan; Zaher Albarqi; Anantharam Devaraj; Mohamed Hessian Mohamed; Ahmed Al-Hakami; Harish C Chandramoorthy
Journal:  Cells       Date:  2018-12-06       Impact factor: 6.600

8.  Epicatechin Gallate Protects HBMVECs from Ischemia/Reperfusion Injury through Ameliorating Apoptosis and Autophagy and Promoting Neovascularization.

Authors:  Bing Fu; Qinghong Zeng; Zhaoting Zhang; Mingyue Qian; Jiechun Chen; Wanli Dong; Min Li
Journal:  Oxid Med Cell Longev       Date:  2019-03-06       Impact factor: 6.543

9.  Blockade of HCN2 Channels Provides Neuroprotection Against Ischemic Injury via Accelerating Autophagic Degradation in Hippocampal Neurons.

Authors:  Cheng Chen; Li Liu; Ya-Qiao Shu; Ping Jing; Yun Lu; Xiao-Xue Zhang; Xian-Gang Zong; Lian-Jun Guo; Chang-Jun Li
Journal:  Neurosci Bull       Date:  2020-06-10       Impact factor: 5.203

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.